New insights into in vitro amyloidogenic properties of human serum albumin suggest considerations for therapeutic precautions

FEBS Letters

Volumn 589, Issue 24, 2015, Pages 4033-4038

  Sharma, Neetu ^a   Sivalingam, Vishwanath ^a   Maurya, Sonalika ^a   Prasad, Archana ^a   Khandelwal, Puneet ^b   Yadav, Subhash Chandra ^c   Patel, Basant K ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY HYDERABAD   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Drug carrier; HSA amyloid; Plasma expander; Sarkosyl; Self seeding

Indexed keywords

DIMER; HUMAN SERUM ALBUMIN; HYDROGEN PEROXIDE; MONOMER; UREA; ALB PROTEIN, HUMAN; AMYLOID PROTEIN; CYSTEINE; DETERGENT; DRUG CARRIER; OXIDIZING AGENT; PLASMA SUBSTITUTE; RECOMBINANT PROTEIN; SARCOSINE; SARKOSYL; SERUM ALBUMIN;

AMYLOID AGGREGATION; AMYLOIDOGENIC PROPERTY; ARTICLE; ATOMIC FORCE MICROSCOPY; BETA SHEET; CALIBRATION; CONTROLLED STUDY; CROSS LINKING; DENATURATION; DETERGENT SARKOSYL STABILITY; DISULFIDE BOND; HOMODIMERIZATION; IN VITRO STUDY; MOLECULAR SIZE; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; ROOM TEMPERATURE; SELF SEEDING POTENTIAL; TEMPERATURE DEPENDENCE; TRANSMISSION ELECTRON MICROSCOPY; ANALOGS AND DERIVATIVES; CHEMISTRY; COMPARATIVE STUDY; DIMERIZATION; GENETICS; HUMAN; MOLECULAR WEIGHT; OXIDATION REDUCTION REACTION; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN STABILITY; SIZE EXCLUSION CHROMATOGRAPHY; ULTRASTRUCTURE;

AMYLOIDOGENIC PROTEINS; CHROMATOGRAPHY, GEL; CYSTEINE; DETERGENTS; DIMERIZATION; DRUG CARRIERS; HUMANS; HYDROGEN PEROXIDE; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR WEIGHT; OXIDANTS; OXIDATION-REDUCTION; PLASMA SUBSTITUTES; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN STABILITY; RECOMBINANT PROTEINS; SARCOSINE; SERUM ALBUMIN;

EID: 84959524549     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2015.11.004     Document Type: Article

References (36)

1. F. Chiti, C.M. Dobson, Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem., 75, (2006), 333-366.
2. T. Eichner, S.E. Radford, A diversity of assembly mechanisms of a generic amyloid fold. Mol. Cell, 43, (2011), 8-18.
3. R. Nelson, M.R. Sawaya, M. Balbirnie, A.O. Madsen, C. Riekel, R. Grothe, D. Eisenberg, Structure of the cross-beta spine of amyloid-like fibrils. Nature, 435, (2005), 773-778.
4. D.M. Fowler, A.V. Koulov, W.E. Balch, J.W. Kelly, Functional amyloid-from bacteria to humans. Trends Biochem. Sci., 32, (2007), 217-224.
5. N.K. Holm, Aggregation and fibrillation of bovine serum albumin. Biochim. Biophys. Acta, 1774, (2007), 1128-1138.
6. P. Taboada, S. Barbosa, E. Castro, V. Mosquera, Amyloid fibril formation and other aggregate species formed by human serum albumin association. J. Phys. Chem. B, 110, (2006), 20733-20736.
7. S.K. Maji, Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science, 325, (2009), 328-332.
8. B.K. Patel, J. Gavin-Smyth, S.W. Liebman, The yeast global transcriptional co-repressor protein Cyc8 can propagate as a prion. Nat. Cell Biol., 11, (2009), 344-349.
9. J. Juarez, P. Taboada, V. Mosquera, Existence of different structural intermediates on the fibrillation pathway of human serum albumin. Biophys. J., 96, (2009), 2353-2370.
10. S. Sugio, A. Kashima, S. Mochizuki, M. Noda, K. Kobayashi, Crystal structure of human serum albumin at 2.5 A resolution. Protein Eng., 12, (1999), 439-446.
11. G. Fanali, A. di Masi, V. Trezza, M. Marino, M. Fasano, P. Ascenzi, Human serum albumin: from bench to bedside. Mol. Aspects Med., 33, (2012), 209-290.
12. F. Yang, Y. Zhang, H. Liang, Interactive association of drugs binding to human serum albumin. Int. J. Mol. Sci., 15, (2014), 3580-3595.
13. G.J. Quinlan, G.S. Martin, T.W. Evans, Albumin: biochemical properties and therapeutic potential. Hepatology, 41, (2005), 1211-1219.
14. K. Taguchi, V.T. Chuang, T. Maruyama, M. Otagiri, Pharmaceutical aspects of the recombinant human serum albumin dimer: structural characteristics, biological properties, and medical applications. J. Pharm. Sci., 101, (2012), 3033-3046.
15. S. Matsushita, V.T. Chuang, M. Kanazawa, S. Tanase, K. Kawai, T. Maruyama, A. Suenaga, M. Otagiri, Recombinant human serum albumin dimer has high blood circulation activity and low vascular permeability in comparison with native human serum albumin. Pharm. Res., 23, (2006), 882-891.
16. N.K. Pandey, S. Ghosh, D.R. Tripathy, S. Dasgupta, Effect of temperature and solvent on fibrillation of human serum albumin. Protein Pept. Lett., 22, (2015), 112-118.
17. J. Juarez, M. Alatorre-Meda, A. Cambon, A. Topete, S. Barbosa, P. Taboada, V. Mosquera, Hydration effects on the fibrillation process of a globular protein: the case of human serum albumin. Soft Matter, 8, (2012), 3608-3619.
18. S.R. Collins, A. Douglass, R.D. Vale, J.S. Weissman, Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol., 2, (2004), e321 -
19. B.K. Patel, S.W. Liebman, "Prion-proof" for [PIN+]: infection with in vitro-made amyloid aggregates of Rnq1p-(132-405) induces [PIN+]. J. Mol. Biol., 365, (2007), 773-782.
20. J. Juarez, S.G. Lopez, A. Cambon, P. Taboada, V. Mosquera, Influence of electrostatic interactions on the fibrillation process of human serum albumin. J. Phys. Chem. B, 113, (2009), 10521-10529.
21. H. LeVine 3rd., Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci., 2, (1993), 404-410.
22. W.E. Klunk, R.F. Jacob, R.P. Mason, Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay. Anal. Biochem., 266, (1999), 66-76.
23. S.B. Prusiner, Novel proteinaceous infectious particles cause scrapie. Science, 216, (1982), 136-144.
24. V. Taneja, M.L. Maddelein, N. Talarek, S.J. Saupe, S.W. Liebman, A non-Q/N-rich prion domain of a foreign prion, [Het-s], can propagate as a prion in yeast. Mol. Cell, 27, (2007), 67-77.
25. S.N. Bagriantsev, V.V. Kushnirov, S.W. Liebman, Analysis of amyloid aggregates using agarose gel electrophoresis. Methods Enzymol., 412, (2006), 33-48.
26. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, (1970), 680-685.
27. Y. Furukawa, K. Kaneko, S. Watanabe, K. Yamanaka, N. Nukina, A seeding reaction recapitulates intracellular formation of sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J. Biol. Chem., 286, (2011), 18664-18672.
28. J.D. Harper, P.T. Lansbury Jr., Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem., 66, (1997), 385-407.
29. G.L. Francis, Albumin and mammalian cell culture: implications for biotechnology applications. Cytotechnology, 62, (2010), 1-16.
30. G.L. Ellman, Tissue sulfhydryl groups. Arch. Biochem. Biophys., 82, (1959), 70-77.
31. S.J. Burton, A.V. Quirk, P.C. Wood, Refolding human serum albumin at relatively high protein concentration. Eur. J. Biochem., 179, (1989), 379-387.
32. C.A. Schneider, W.S. Rasband, K.W. Eliceiri, NIH image to ImageJ: 25 years of image analysis. Nat. Methods, 9, (2012), 671-675.
33. S. Arya, A. Kumari, V. Dalal, M. Bhattacharya, S. Mukhopadhyay, Appearance of annular ring-like intermediates during amyloid fibril formation from human serum albumin. Phys. Chem. Chem. Phys., 17, (2015), 22862-22871.
34. C.Q. Chen, W. Lin, A.G. Coombes, S.S. Davis, L. Illum, Preparation of human serum albumin microspheres by a novel acetone-heat denaturation method. J. Microencapsul., 11, (1994), 395-407.
35. A. Aguzzi, C. Sigurdson, M. Heikenwaelder, Molecular mechanisms of prion pathogenesis. Annu. Rev. Pathol., 3, (2008), 11-40.
36. S.B. Prusiner, Prions. Proc. Natl. Acad. Sci. USA, 95, (1998), 13363-13383.